Suppr超能文献

同时使用非典型抗精神病药物和合成大麻素导致横纹肌溶解症和需要透析的急性肾损伤

Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids.

作者信息

Zhao Aiyu, Tan Maybel, Maung Aung, Salifu Moro, Mallappallil Mary

机构信息

State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.

出版信息

Case Rep Nephrol. 2015;2015:235982. doi: 10.1155/2015/235982. Epub 2015 Oct 13.

Abstract

The use of synthetic cannabinoids (SCBs) is associated with many severe adverse effects that are not observed with marijuana use. We report a unique case of a patient who developed rhabdomyolysis and acute kidney injury (AKI) requiring dialysis after use of SCBs combined with quetiapine. Causes for the different adverse effects profile between SCBs and marijuana are not defined yet. Cases reported in literature with SCBs use have been associated with reversible AKI characterized by acute tubular necrosis and interstitial nephritis. Recent studies have showed the involvement of cytochromes P450s (CYPs) in biotransformation of SCBs. The use of quetiapine which is a substrate of the CYP3A4 and is excreted (73%) as urine metabolites may worsen the side effect profiles of both quetiapine and K2. SCBs use should be included in the differential diagnosis of AKI and serum Creatinine Phosphokinase (CPK) level should be monitored. Further research is needed to identify the mechanism of SCBs nephrotoxicity.

摘要

合成大麻素(SCBs)的使用与许多严重不良反应相关,而使用大麻则不会出现这些不良反应。我们报告了一例独特的病例,一名患者在使用SCBs联合喹硫平后发生横纹肌溶解和急性肾损伤(AKI),需要进行透析。SCBs和大麻之间不良反应谱不同的原因尚未明确。文献报道的使用SCBs的病例与以急性肾小管坏死和间质性肾炎为特征的可逆性AKI有关。最近的研究表明细胞色素P450(CYPs)参与了SCBs的生物转化。喹硫平是CYP3A4的底物,以尿液代谢物形式排泄(73%),使用喹硫平可能会使喹硫平和K2的副作用加剧。AKI的鉴别诊断应包括SCBs的使用情况,并且应监测血清肌酸磷酸激酶(CPK)水平。需要进一步研究以确定SCBs肾毒性的机制。

相似文献

2
Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists.
Stem Cell Investig. 2017 May 26;4:43. doi: 10.21037/sci.2017.05.05. eCollection 2017.
3
Synthetic Cannabinoids.
Am J Med Sci. 2015 Jul;350(1):59-62. doi: 10.1097/MAJ.0000000000000466.
4
[Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
Fortschr Neurol Psychiatr. 2015 Apr;83(4):221-31. doi: 10.1055/s-0034-1399307. Epub 2015 Apr 20.
5
Rhabdomyolysis-Associated Acute Kidney Injury With Normal Creatine Phosphokinase.
Am J Med Sci. 2018 Jan;355(1):84-87. doi: 10.1016/j.amjms.2017.04.014. Epub 2017 Apr 24.
6
Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
Clin Schizophr Relat Psychoses. 2015 Jan;8(4):205-8. doi: 10.3371/CSRP.DUDE.031513.
10
Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion.
N Am J Med Sci. 2016 Jun;8(6):256-8. doi: 10.4103/1947-2714.185038.

引用本文的文献

1
Conceptualizing the relationship between synthetic cannabinoid use and neuroleptic malignant syndrome.
Bipolar Disord. 2025 Mar;27(2):161-162. doi: 10.1111/bdi.13503. Epub 2024 Sep 1.
2
Poisoning-Induced Acute Kidney Injury: A Review.
Medicina (Kaunas). 2024 Aug 12;60(8):1302. doi: 10.3390/medicina60081302.
3
Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.
Biomedicines. 2022 Aug 10;10(8):1936. doi: 10.3390/biomedicines10081936.
4
Designer drugs: mechanism of action and adverse effects.
Arch Toxicol. 2020 Apr;94(4):1085-1133. doi: 10.1007/s00204-020-02693-7. Epub 2020 Apr 6.
5
Quetiapine-related Acute Kidney Injury Requiring Transient Continuous Hemodiafiltration.
Intern Med. 2018 Jun 15;57(12):1763-1767. doi: 10.2169/internalmedicine.0170-17. Epub 2018 Feb 9.
6
Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.
BMC Nephrol. 2017 Dec 29;18(1):379. doi: 10.1186/s12882-017-0794-0.
7
Short-Term High-Dose Steroid Therapy in a Case of Rhabdomyolysis Refractory to Intravenous Fluids.
Am J Case Rep. 2017 Oct 17;18:1110-1113. doi: 10.12659/AJCR.905196.
8
McArdle disease: a "pediatric" disorder presenting in an adult with acute kidney injury.
CEN Case Rep. 2017 Nov;6(2):156-160. doi: 10.1007/s13730-017-0265-2. Epub 2017 Jun 28.
9
What Do We Know about Opioids and the Kidney?
Int J Mol Sci. 2017 Jan 22;18(1):223. doi: 10.3390/ijms18010223.
10
Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion.
N Am J Med Sci. 2016 Jun;8(6):256-8. doi: 10.4103/1947-2714.185038.

本文引用的文献

2
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
Drug Alcohol Depend. 2014 Nov 1;144:12-41. doi: 10.1016/j.drugalcdep.2014.08.005. Epub 2014 Aug 18.
3
5
A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics.
Psychosomatics. 2014 Jul-Aug;55(4):404-408. doi: 10.1016/j.psym.2013.05.003. Epub 2013 Sep 7.
6
Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
Clin Schizophr Relat Psychoses. 2015 Jan;8(4):205-8. doi: 10.3371/CSRP.DUDE.031513.
8
AKI associated with synthetic cannabinoids: a case series.
Clin J Am Soc Nephrol. 2013 Apr;8(4):523-6. doi: 10.2215/CJN.05690612. Epub 2012 Dec 14.
9
Synthetic cannabinoid intoxication: a case series and review.
J Emerg Med. 2013 Feb;44(2):360-6. doi: 10.1016/j.jemermed.2012.07.061. Epub 2012 Sep 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验